Market Tracker

09/16 6:05pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.28
Data as of Sep 16
 +0.01 / +0.79%
Today’s Change
1.11
Today|||52-Week Range
2.90
-38.16%
Year-to-Date

Today’s Trading

Previous close1.27
Today’s open1.27
Day’s range1.26 - 1.29
Volume330,636
Average volume (3 months)597,996
Market cap$191.3M
Dividend yield--
Data as of 4:03pm ET, 09/16/2014

Growth & Valuation

Earnings growth (last year)-18.72%
Earnings growth (this year)+20.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,335.94%
P/E ratioNM
Price/Sales223.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
STMLStemline Therapeutic...-0.65-4.51%
AMPEAmpio Pharmaceutical...0.000.00%
NNVCNanoViricides Inc+0.14+3.94%
ELTPElite Pharmaceutical...+0.00+1.18%
Data as of 4:01pm ET, 09/16/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.1M
Annual profit (last year)-$42.7M
Net profit margin-3,776.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mike M. Goldberg
President &
Chief Business Officer
Thomas H. Tulip
Corporate headquarters
Dublin, Ohio

Forecasts